Drug company Elan says it will record an operating profit in 2010 following a decade of losses.

Elan this morning reported an 11% growth in revenue to more than US$1.1 billion dollars and has more than halved its net losses over the year.

The neuroscience-based biotechnology company is headquartered in Dublin.